Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/Latest News/Revolutionary Study Reveals New Strategies to Combat Dengue Fever
Revolutionary Study Reveals New Strategies to Combat Dengue Fever
Latest News

Revolutionary Study Reveals New Strategies to Combat Dengue Fever

By adminitfy
August 12, 2025 3 Min Read

The components of the immune response that protect humans from dengue virus (DENV) infections remain largely unsolved, posing challenges for researchers seeking to enhance vaccine development. A recent study has shed light on how to strengthen immunity against DENV. Scientists from the US and Philippines discovered that specific antibodies, termed envelope dimer epitope (EDE)-like antibodies, are crucial for establishing broad immunity against various DENV serotypes following either natural infection or vaccination. This research, published in Science Translational Medicine, represents a significant advancement in understanding dengue immunity and could pave the way for more effective treatments.

Dengue fever, a major global health concern caused by four distinct DENV serotypes, is the most prevalent vector-borne viral disease, placing nearly half of the world’s population at risk, particularly in Southeast Asia, Africa, and the Americas. A 2013 study revealed that the economic burden of dengue in Southeast Asia surpasses that of diseases such as Japanese encephalitis and hepatitis B. However, creating a universally effective vaccine has been complex due to intricate immune mechanisms. In fact, the initial immune response to a person’s first DENV infection can ironically increase the risk of severe illness during subsequent infections with different DENV serotypes-a phenomenon known as antibody-dependent enhancement. This occurs when non-neutralizing antibodies bind to immature virus particles, allowing them to enter immune cells and exacerbate the infection. All severe cases requiring hospitalization arise from such second infections.

As vaccines aim to simulate natural infections, the risk of antibody-dependent enhancement complicates dengue vaccine strategies, leading to recommendations only for those with prior exposure to the virus. Genuine protection, known as “secondary immunity,” develops after exposure to at least two different DENV serotypes. Two primary vaccines-Dengvaxia and QDENGA-are currently licensed in some regions and are most effective for those previously infected with dengue, necessitating laboratory confirmation of previous infections for Dengvaxia.

In June 2017, a significant dengue outbreak occurred in Cebu, Philippines, following the administration of the vaccine to children aged 9-14. The researchers tracked a cohort of 2,996 children, with 1,782 receiving the vaccine. Blood samples were collected before vaccination and again 17 to 28 months later, coinciding with the outbreak, predominantly caused by DENV2. The team analyzed various antibody types, including EDE-like antibodies, neutralizing antibodies, and binding antibodies.

Findings underscored the pivotal role of EDE-like antibodies, noted for their high prevalence in children with secondary immunity-between 81.8% and 90.1% had detectable levels. In contrast, EDE-like antibodies were rarely found in those who had only primary immunity (4%-12%). This suggests that EDE-like antibodies are instrumental in establishing immunity against dengue. The quantity of EDE-like antibodies was strongly correlated with neutralization across all four DENV serotypes, indicating their importance for broad protection.

The study revealed that both natural DENV infections during the outbreak and vaccination significantly increased EDE-like antibodies, along with binding and neutralizing antibodies, even among children with existing secondary immunity. Higher EDE-like antibody levels were consistently linked to a reduced likelihood of symptomatic dengue and hospitalization, showcasing their protective effects across multiple serotypes. However, these antibodies displayed limited capacity to prevent viral replication, making them less effective against new infections but more protective against severe disease.

Perhaps the most crucial observation was that EDE-like antibodies statistically accounted for a significant portion of the protective effects of other antibodies. When incorporated into statistical models, the impact of other antibodies diminished, suggesting EDE-like antibodies are a primary determinant of broad immunity against dengue.

Despite certain limitations, such as a limited number of dengue cases assessed for protection against all serotypes, this study marks a notable advancement in dengue research. The findings help elucidate the immune responses necessary for protection, with EDE-like antibodies demonstrating how other antibody types contribute to defense. Further studies will be essential to formally validate EDE-like antibodies as reliable indicators of vaccine efficacy. Successfully validating these antibodies could lead to the design of vaccines that elicit higher levels of EDE-like antibodies, ultimately enhancing protection against dengue.

Original Source: https://www.thehindu.com/sci-tech/science/landmark-study-offers-new-insights-into-what-protects-against-dengue/article69918933.ece
Category:
Tags:
Publish Date: 2025-08-12 05:30:00

Author

adminitfy

Follow Me
Other Articles
Previous

Unleash Your Employees: The Powerful New Mavericks Driving Your Marketing Success!

Next

Tragedy Strikes Bengaluru: Assembly Debates Heart-Wrenching Stadium Stampede

No Comment! Be the first one.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search...

Recent Posts

  • From $12B to $3.68B: The New Logic of SaaS Consolidation
    by Sanjeev Sarma
    November 20, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • From $12B to $3.68B: The New Logic of SaaS Consolidation
  • AI Courses in 2027: The Shocking Truth About Learning
  • Fact-Check: No Indian Official Welcomed Musadik Malik in Delhi?
  • Latvia’s Supernova 2027 Buzz: First 16 Songs Unveiled — Listen to the Exclusive Must-Watch Drop!
  • পদত্যাগ অপৰাধ স্বীকাৰ নয়, নিৰ্দোষী যশৱন্ত ভাৰ্মাৰৰ লোকসভা সচিবালয়লৈ পত্ৰ
  • November 2026 (627)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.